HDL-Based Targeted Drug Delivery Platform

NanoLipoMedics is chemically manipulating HDL to facilitate targeted drug delivery while minimizing debilitating off-target effects.

Cancer-specific Nanocarrier Library Development:

Our library of differentially manipulated HDLs holds great potential towards targeting of biomarkers overexpressed to varying degrees in specific cancer types.

Engineered HDL Nanoparticles:

Our nanoparticle engineering platform is novel and innovative with delivery vehicles formulated within a size range that allows for deep penetration into tumor tissue.

Targeted Delivery:

HDL nanoparticle engineering affords tuning of each unique anticancer delivery vehicle for optimal targeting of payload based on cancer type, metastatic phase, the individual, and other key variables.

Safe and Effective Treatment:

Our goal is to build a biocompatible library of drug delivery vehicles that will target and eliminate specific cancers while prioritizing patient safety and quality of life.